Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 3.880
-0.010 (-0.26%)
Apr 17, 2026, 1:05 PM HKT
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.41 billion as of April 17, 2026. Its market cap has decreased by -87.86% in one year.
Market Cap
1.41B
Enterprise Value
842.40M
Revenue
58.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.88
Market Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.41B, a decrease of -81.35%. That is a compound annual growth rate of -68.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.41B | -20.65% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabpharm | 1.81B |
| Cutia Therapeutics | 1.76B |
| Zhaoke Ophthalmology | 1.76B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.72B |
| CANbridge Pharmaceuticals | 1.55B |
| Kintor Pharmaceutical | 1.35B |
| Transcenta Holding | 1.19B |
| Shanghai Bio-heart Biological Technology | 1.09B |